Addressing the needs of cancer survivors during the COVID-19 pandemic
J Cancer Surviv
.
2020 Oct;14(5):601-606.
doi: 10.1007/s11764-020-00884-w.
Authors
Larissa Nekhlyudov
1
,
Saskia Duijts
2
3
,
Shawna V Hudson
4
5
,
Jennifer M Jones
6
7
,
Justin Keogh
8
,
Brad Love
9
,
Maryam Lustberg
10
,
Katherine Clegg Smith
11
,
Amye Tevaarwerk
12
13
,
Xinhua Yu
14
,
Michael Feuerstein
15
Affiliations
1
Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA. lnekhlyudov@partners.org.
2
Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
3
Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.
4
Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, Brunswick, NJ, USA.
5
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
6
Cancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre, Toronto, Canada.
7
Department of Psychiatry, University of Toronto, Toronto, Canada.
8
Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia.
9
Center for Health Communication, Moody College of Communication and Dell Medical School, University of Texas at Austin, Austin, TX, USA.
10
The Ohio State Comprehensive Cancer Center, Columbus, OH, USA.
11
Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
12
Hematology/Oncology, University of Wisconsin-Madison, Madison, WI, USA.
13
Carbone Cancer Center, Madison, WI, USA.
14
Division of Epidemiology, Biostatistics and Environmental Health, University of Memphis, Memphis, TN, USA.
15
The Journal of Cancer Survivorship, Gaithersburg, MD, USA.
PMID:
32335850
PMCID:
PMC7183255
DOI:
10.1007/s11764-020-00884-w
No abstract available
Publication types
Editorial
Comment
MeSH terms
Betacoronavirus
COVID-19
Cancer Survivors*
China
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Survivors